INTERNATIONAL PATENT: SANOFI FILES APPLICATION FOR "BINDING PROTEINS COMPRISING AN ANTI-IMMUNE CHECKPOINT ANTIBODY OR A FRAGMENT THEREOF AND SINGLE-CHAIN TNFRSF LIGAND MULTIMERS"

GENEVA, Dec. 29 -- SANOFI (46 avenue de la Grande Armee75017 PARIS) filed a patent application (PCT/EP2025/067425) for "BINDING PROTEINS COMPRISING AN ANTI-IMMUNE CHECKPOINT ANTIBODY OR A FRAGMENT THEREOF AND SINGLE-CHAIN TNFRSF LIGAND MULTIMERS" on Jun 20, 2025. With publication no. WO/2025/262304, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): OEZGUER BRUDERLE, Sevim (c/o Sanofi- Aventis Deutschland GmbH65926 FRANKFURT AM MAIN), WEIL, Sandra (c/o Sanofi-Aventis Deutschland GmbH65926 FRANKFURT AM...